Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 311

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 311
---
 its Subsidiary as at the respective dates thereof; and                           |

| (iii) | accurately and fairly reflect the basis for the financial statements of the Company at the relevant time. |

A-72

| (b) | Neither the Company nor any Subsidiary of the Company has maintained or maintains any slush fund, off-book account, or unrecorded transactions. |

| 14. | Absence of Certain Changes or Events |

| (i) | paid or satisfied any material obligation or liability, absolute or contingent, other than current liabilities 
 or obligations disclosed in the Financial Statements and in connection with the Discontinuance;                |

| (ii) | declared, set aside or paid any dividend, redeemed or repurchased any outstanding shares, or made any                                                                   
 distribution of its properties or assets to its Shareholders, other than salaries, fees and other compensation paid in each case in connection with the Discontinuance; |

| (iii) | suffered a loss, destruction or damage to any of its assets, whether or not insured, that is material to the 
 Company;                                                                                                     |

| (iv) | authorized or agreed to any change in the terms and conditions of employment of its personnel, including any 
 Employee Plan, other than changes disclosed to the Purchaser in writing;                                     |

| (v) | entered into any collective bargaining agreement or Contract with any employee association, trade union, labour 
 organization or similar entity;                                                                                 |

| (vi) | waived or cancelled any right, claim or debt owed to it; |

| (vii) | transferred, assigned, sold or otherwise disposed of any of its assets exceeding $1,000,000 in value in the 
 aggregate;                                                                                                  |

| (viii) | incurred or assumed or guaranteed any liability, obligation or expenditure of any nature, absolute or                                     
 contingent, other than liabilities incurred in connection with the Discontinuance and in an amount less than $1,000,000 in the aggregate; |

| (ix) | committed to make or perform any capital expenditures or maintenance or repair projects, except for capital                                              
 expenditures or maintenance or repair projects incurred in connection with the Discontinuance with a value not greater than $1,000,000 in the aggregate; |

| (x) | entered into any commitment or transaction not in connection with the Discontinuance; |

| (xi) | entered into or authorized or agreed to any material changes in any Material Contract; |

| (